Tobias Gedde-Dahl

Associate Professor - Department of Haematology
Image of Tobias Gedde-Dahl
Norwegian version of this page
Username
Visiting address Sognsvannsveien 20 OUS Rikshospitalet 0372 Oslo
Postal address Postboks 4950 Nydalen OUS, Rikshospitalet 0424 Oslo

Publications

  • Nagler, Arnon; Galimard, Jacques-Emmanuel; Labopin, Myriam; Blaise, Didier; Arcese, William & Trisolini, Silvia Maria [Show all 15 contributors for this article] (2022). Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT. Cancer Medicine. ISSN 2045-7634. doi: 10.1002/cam4.5039.
  • Swan, Dawn; Hayden, Patrick J.; Eikema, Dirk-Jan; Koster, Linda; Sauer, Sandra & Blaise, Didier [Show all 25 contributors for this article] (2022). Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019. British Journal of Haematology. ISSN 0007-1048. 197(1), p. 82–96. doi: 10.1111/bjh.18025.
  • Nagler, Arnon; Labopin, Myriam; Craddock, Charles; Socié, Gerard; Yakoub-Agha, Ibrahim & Gedde-Dahl, Tobias [Show all 15 contributors for this article] (2022). Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation. American Journal of Hematology. ISSN 0361-8609. 97(3), p. 274–282. doi: 10.1002/ajh.26442.
  • Aasebø, Anders Theodor Michaelsen; Gedde-Dahl, Tobias; Reims, Henrik Mikael; Bækkevold, Espen Sønderaal & Jahnsen, Frode Lars (2022). Calprotectin Expressing Donor-Derived Macrophages Increase in Acute Gastrointestinal Graft-Versus-Host Disease. Transplantation and Cellular Therapy (TCT). ISSN 2666-6375. 28(5), p. 248.e1–248.e8. doi: 10.1016/j.jtct.2022.01.028.
  • Remberger, Mats; Tjønnfjord, Geir Erland; Abrahamsen, Ingerid Weum; Ali, Maryan Mohamed; Myhre, Anders Eivind & Gedde-Dahl, Tobias [Show all 7 contributors for this article] (2021). Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG. Transplantation and Cellular Therapy (TCT). ISSN 2666-6375. 27(7), p. 621.e1–621.e3. doi: 10.1016/j.jtct.2021.03.019.
  • Ali, Maryan Mohamed; Grønvold, Bjørn Christer Linder; Remberger, Mats; Abrahamsen, Ingerid Weum; Myhre, Anders Eivind & Tjønnfjord, Geir Erland [Show all 8 contributors for this article] (2021). Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival. Clinical Lymphoma, Myeloma & Leukemia. ISSN 2152-2650. 21(9), p. 598–605. doi: 10.1016/j.clml.2021.05.003. Full text in Research Archive
  • Waidhauser, Johanna; Labopin, Myriam; Esteve, Jordi; Kröger, Nicolaus; Cornelissen, Jan & Gedde-Dahl, Tobias [Show all 17 contributors for this article] (2021). Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT. Bone Marrow Transplantation. ISSN 0268-3369. 56(10), p. 2445–2453. doi: 10.1038/s41409-021-01322-w.
  • Cesaro, Simone; Tridello, Gloria; Knelange, Nina Simone; Blijlevens, Nicole; Martin, Murray & Snowden, JA [Show all 29 contributors for this article] (2021). Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP–EBMT. Bone Marrow Transplantation. ISSN 0268-3369. 56(7), p. 1563–1572. doi: 10.1038/s41409-021-01212-1.
  • Nagler, Arnon; Labopin, Myriam; Dholaria, Bhagirathbhai; Wu, Depei; Choi, Goda & Aljurf, Mahmoud [Show all 24 contributors for this article] (2021). Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation. Transplantation and Cellular Therapy (TCT). ISSN 2666-6375. doi: 10.1016/j.jtct.2021.11.013.
  • Jørgensen, Silje Fjellgård; Buechner, Jochen; Myhre, Anders Eivind; Galteland, Eivind; Spetalen, Signe & Kulseth, Mari Ann [Show all 19 contributors for this article] (2021). A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT. Journal of Clinical Immunology. ISSN 0271-9142. doi: 10.1007/s10875-021-01189-y. Full text in Research Archive
  • Kharfan-Dabaja, Mohamed A.; Labopin, Myriam; Bazarbachi, Ali; Ciceri, Fabio; Finke, J. & Bruno, Benedetto [Show all 29 contributors for this article] (2021). Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT. Bone Marrow Transplantation. ISSN 0268-3369. 56(9), p. 2194–2202. doi: 10.1038/s41409-021-01317-7.
  • Flygt, Hjalmar; Söderlund, Stina; Stentoft, Jesper; Richter, Johan; Koskenvesa, Perttu & Mustjoki, Satu [Show all 18 contributors for this article] (2021). Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study. European Journal of Haematology. ISSN 0902-4441. p. 1–7. doi: 10.1111/ejh.13699.
  • Richter, Johan; Lübking, Anna; Söderlund, Stina; Lotfi, Kourosh; Markevärn, Berit & Själander, Anders [Show all 19 contributors for this article] (2021). Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI. Leukemia. ISSN 0887-6924. 35, p. 2416–2418. doi: 10.1038/s41375-021-01173-w.
  • Andersen, Anders Mikal; Bergan, Stein; Gedde-Dahl, Tobias; Buechner, Jochen & Vethe, Nils Tore (2021). Fast and reliable quantification of busulfan in blood plasma using two-channel liquid chromatography tandem mass spectrometry: Validation of assay performance in the presence of drug formulation excipients. Journal of Pharmaceutical and Biomedical Analysis. ISSN 0731-7085. 203, p. 1–11. doi: 10.1016/j.jpba.2021.114216. Full text in Research Archive
  • Giebel, Sebastian; Labopin, Myriam; Sobczyk-Kruszelnicka, Malgorzata; Stelljes, Matthias; Byrne, Jenny L. & Fegueux, Nathalie [Show all 100 contributors for this article] (2021). Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplantation. ISSN 0268-3369. 56(2), p. 481–491. doi: 10.1038/s41409-020-01050-7.
  • Halaburda, Kazimierz; Labopin, Myriam; Mailhol, Audrey; Socié, Gérard; Craddock, Charles & Aljurf, Mahmoud [Show all 18 contributors for this article] (2020). Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: A study from the acute leukemia working party of the european society for blood and marrow transplantation. Haematologica. ISSN 0390-6078. 105(6), p. 1723–1730. doi: 10.3324/haematol.2019.222810.
  • Divito, Sherrie J.; Aasebø, Anders Theodor Michaelsen; Matos, Tiago R.; Hsieh, Pei-Chen; Collin, Matthew & Elco, Christopher P. [Show all 25 contributors for this article] (2020). Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease. Journal of Clinical Investigation. ISSN 0021-9738. 130(9), p. 4624–4636. doi: 10.1172/JCI129965.
  • Tadele, Dagim Shiferaw; Robertson, Joseph; Crispin, Richard; Herrera, Carmen; Chlubnová, Markéta & Piechaczyk, Laure Isabelle [Show all 14 contributors for this article] (2020). A cell competition-based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation. Journal of Biological Chemistry. ISSN 0021-9258. 296. doi: 10.1074/jbc.RA120.015285.
  • Tvedt, Tor Henrik Anderson; Skaarud, Kristin Aneta Joan; Tjønnfjord, Geir Erland; Gedde-Dahl, Tobias; Iversen, Per Ole & Bruserud, Øystein (2020). The systemic metabolic profile early after allogeneic stem cell transplantation: Effects of adequate energy support administered through enteral feeding tube. Biology of Blood and Marrow Transplantation. ISSN 1083-8791. 26(2), p. 380–391. doi: 10.1016/j.bbmt.2019.10.005.
  • Gilleece, Maria H; Labopin, Myriam; Savani, Bipin N; Yakoub-Agha, Ibrahim; Socié, Gérard & Gedde-Dahl, Tobias [Show all 16 contributors for this article] (2019). Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT. Leukemia. ISSN 0887-6924. 34(1), p. 87–99. doi: 10.1038/s41375-019-0527-4.
  • Cremers, Eline M.P.; de Witte, Theo; De Wreede, Liesbeth C.; Eikema, Diderik-Jan; Koster, Linda & van Biezen, Anja A. [Show all 24 contributors for this article] (2019). A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation. Leukemia and Lymphoma. ISSN 1042-8194. 60(10), p. 2404–2414. doi: 10.1080/10428194.2019.1594215.
  • Passweg, Jakob Robert; Labopin, Myriam; Christopeit, Maximillian; Cornelissen, Jan J.; Pabst, Thomas & Soçie, Gérard J. [Show all 19 contributors for this article] (2019). Postremission consolidation by autologous hematopoietic cell transplantation (HCT) for acute myeloid leukemia in first complete remission (CR) and negative implications for subsequent allogeneic HCT in second CR: A study by the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT). Biology of Blood and Marrow Transplantation. ISSN 1083-8791. p. 1–6. doi: 10.1016/j.bbmt.2019.11.021. Full text in Research Archive
  • Wiktor-Jedrzejczak, W.; Drozd-Sokolowska, J; Eikema, DJ; Hoek, J; Potter, M & Wulf, G [Show all 32 contributors for this article] (2019). EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL). Bone Marrow Transplantation. ISSN 0268-3369. doi: 10.1038/s41409-019-0448-x.
  • Søraas, Arne Vasli; Matsuyama, Mieko; de Lima, Marcos; Wald, David; Buechner, Jochen & Gedde-Dahl, Tobias [Show all 12 contributors for this article] (2019). Epigenetic age is a cell-intrinsic property in transplanted human hematopoietic cells. Aging Cell. ISSN 1474-9718. 18(2). doi: 10.1111/acel.12897. Full text in Research Archive
  • Reikvam, Håkon; Skavland, Jørn; Gullaksen, Stein-Erik; Hovland, Randi; Gedde-Dahl, Tobias & Bruserud, Øystein [Show all 7 contributors for this article] (2018). Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation. Case reports in hematology. ISSN 2090-6560. doi: 10.1155/2018/2045985. Full text in Research Archive
  • Lorentino, Francesca; Labopin, Myriam; Bernardi, Massimo; Ciceri, Fabio; Socié, Gérard & Cornelissen, Jan J. [Show all 18 contributors for this article] (2018). Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission. American Journal of Hematology. ISSN 0361-8609. 93(10), p. 1236–1244. doi: 10.1002/ajh.25231.
  • McLornan, Donal P; Szydlo, Richard; Robin, Marie; Van Biezen, Anja A.; Koster, Linda & Blok, Henrik J P [Show all 27 contributors for this article] (2018). Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT. British Journal of Haematology. ISSN 0007-1048. 182(3), p. 418–422. doi: 10.1111/bjh.15407.
  • Danylesko, Ivetta; Bukauskas, Adomas; Paulson, Martin; Peceliunas, Valdas; Gedde-Dahl, Tobias & Shimoni, Avichai [Show all 10 contributors for this article] (2018). Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease. Bone Marrow Transplantation. ISSN 0268-3369. doi: 10.1038/s41409-018-0364-5.
  • Tangen, Jon-Magnus; Tjønnfjord, Geir Erland; Gulbrandsen, Nina; Gedde-Dahl, Thobias; Stormorken, Espen & Anderson, Kristina [Show all 9 contributors for this article] (2018). Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001-2010: A retrospective, population based analysis. BMC Cancer. ISSN 1471-2407. 18:801, p. 1–9. doi: 10.1186/s12885-018-4722-x. Full text in Research Archive
  • Tvedt, Tor Henrik Anderson; Hovland, Randi; Tsykunova, Galina; Ahmed, Aymen B; Gedde-Dahl, Thobias & Bruserud, Øyvind (2018). A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation. Clinical and Experimental Immunology. ISSN 0009-9104. 193(1), p. 130–141. doi: 10.1111/cei.13124. Full text in Research Archive
  • Lazarević, Vladimir L.J.; Labopin, Myriam; Depei, Wu; Yakoub-Agha, Ibrahim; Huynh, Anne & Ljungman, Per [Show all 16 contributors for this article] (2018). Relatively favorable outcome after allogeneic stem cell transplantation for BCR‐ABL1‐positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT). American Journal of Hematology. ISSN 0361-8609. 93(1), p. 31–39. doi: 10.1002/ajh.24928.
  • Canaani, Jonathan; Labopin, Myriam; Socié, Gérard; Nihtinen, Anne; Huynh, Anne & Cornelissen, Jan [Show all 14 contributors for this article] (2017). Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT. American Journal of Hematology. ISSN 0361-8609. 92(7), p. 653–659. doi: 10.1002/ajh.24737.
  • Canaani, Jonathan; Beohou, Eric; Labopin, Myriam; Socie, Gerard; Huynh, Anne & Volin, Liisa [Show all 14 contributors for this article] (2017). Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT. American Journal of Hematology. ISSN 0361-8609. 92(4), p. 344–350. doi: 10.1002/ajh.24640.
  • Gullaksen, Stein-Erik; Skavland, Jørn; Gavasso, Sonia; Tosevski, Vinko; Warzocha, Krzysztof & Dumrese, Claudia [Show all 29 contributors for this article] (2017). Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib. Haematologica. ISSN 0390-6078. 102(8), p. 1361–1367. doi: 10.3324/haematol.2017.167080. Full text in Research Archive
  • Ilander, Mette; Olsson-Strömberg, Ulla; Schlums, Heinrich; Guilhot, Joëlle; Brück, Oscar & Lähteenmäki, Hanna [Show all 31 contributors for this article] (2017). Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia. Leukemia. ISSN 0887-6924. 31(5), p. 1108–1116. doi: 10.1038/leu.2016.360.
  • van Gelder, Michel; De Wreede, Liesbeth C.; Bornhäuser, Martin; Niederwieser, Dietger Walter; Karaś, Michael & Anderson, Niels Smedsgaard [Show all 31 contributors for this article] (2017). Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplantation. ISSN 0268-3369. 52(3), p. 372–380. doi: 10.1038/bmt.2016.282.
  • Robin, M; Porcher, R; Zinke-Cerwenka, W; van Biezen, A.; Volin, L. & Mufti, G [Show all 22 contributors for this article] (2017). Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: A retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT. Bone Marrow Transplantation. ISSN 0268-3369. 52(2), p. 209–215. doi: 10.1038/bmt.2016.266.
  • Poiré, Xavier; Labopin, Myriam; Maertens, Johan; Yakoub-Agha, Ibrahim; Blaise, Didier & Ifrah, Norbert [Show all 16 contributors for this article] (2017). Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT). Journal of Hematology & Oncology. ISSN 1756-8722. 10(1), p. 1–10. doi: 10.1186/s13045-017-0393-3.
  • Fløisand, Yngvar; Lundin, Knut Erik Aslaksen; Lazarevic, Vladimir; Kristiansen, Jørn Dehli; Osnes, Liv T. N. & Tjønnfjord, Geir Erland [Show all 8 contributors for this article] (2016). Targeting integrin α4β7 in steroid-refractory intestinal graft-versus-host disease. Biology of Blood and Marrow Transplantation. ISSN 1083-8791. 23(1), p. 172–175. doi: 10.1016/j.bbmt.2016.10.009.
  • Hjorth-Hansen, Henrik; Stentoft, Jesper; Richter, Johan; Koskenvesa, Perttu; Höglund, Martin & Dreimane, Arta [Show all 20 contributors for this article] (2016). Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients. Leukemia. ISSN 0887-6924. 30(9), p. 1853–1860. doi: 10.1038/leu.2016.121.
  • Bremer, Sara; Fløisand, Yngvar; Brinch, Lorentz; Gedde-Dahl, Thobias & Bergan, Stein (2015). Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome after Myeloablative Conditioning. Therapeutic Drug Monitoring. ISSN 0163-4356. 37(4), p. 493–500. doi: 10.1097/FTD.0000000000000180.
  • Hjorth-Hansen, Henrik; Stenke, Leif; Söderlund, Stina; Dreimane, Arta; Ehrencrona, Hans & Gedde-Dahl, Thobias [Show all 20 contributors for this article] (2015). Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: Clinical results from a randomised phase-2 study (NordCML006). European Journal of Haematology. ISSN 0902-4441. 94(3), p. 243–250. doi: 10.1111/ejh.12423. Full text in Research Archive
  • Hallstensen, Randi; Bergseth, Grete; Foss, Stian; Jæger, Steinar; Gedde-Dahl, Thobias & Holt, jan [Show all 14 contributors for this article] (2015). Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn. Immunobiology. ISSN 0171-2985. 220(4), p. 452–459. doi: 10.1016/j.imbio.2014.11.003. Full text in Research Archive
  • Bruserud, Øystein; Tvedt, Tor Henrik Anderson; Quist-Paulsen, Petter; Ahmed, Aymen B; Gedde-Dahl, Thobias & Tjønnfjord, Geir Erland [Show all 9 contributors for this article] (2014). Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: Immunological mechanisms and the results from clinical studies. Cancer Immunology and Immunotherapy. ISSN 0340-7004. 63(8), p. 757–777. doi: 10.1007/s00262-014-1578-z.
  • Mustjoki, Satu; Richter, Johan; Barbany, Gisela; Ehrencrona, Hans; Fioretos, Thoas & Gedde-Dahl, Thobias [Show all 21 contributors for this article] (2013). Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients. Leukemia. ISSN 0887-6924. 27(7), p. 1520–1526. doi: 10.1038/leu.2013.19.
  • Mellqvist, Ulf-Henrik; Gimsing, Peter; Hjertner, Øyvind; Lenhoff, Stig; Laane, Edward & Remes, Kari [Show all 25 contributors for this article] (2013). Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial. Blood. ISSN 0006-4971. 121(23), p. 4647–4654. doi: 10.1182/blood-2012-11-464503.
  • Gruber, Franz; Lundan, Tuija; Goll, Rasmus; Silye, Aleksandra; Mikkola, Ingvild & Rekvig, Ole Petter [Show all 11 contributors for this article] (2012). BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations? Medical Oncology (MO). ISSN 1357-0560. 29(1), p. 219–226. doi: 10.1007/s12032-010-9781-z.
  • Fløisand, Yngvar; Brinch, Lorentz; Gedde-Dahl, Thobias; Tjønnfjord, Geir Erland; Dybedal, Ingunn & Holte, Harald [Show all 18 contributors for this article] (2012). Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. ISSN 0268-3369. 47(12), p. 1552–1557. doi: 10.1038/bmt.2012.63.
  • Simonsson, B; Gedde-Dahl, Tobias; Markevärn, B; Remes, Kari; Stentoft, Jesper & Almqvist, Anders [Show all 28 contributors for this article] (2011). Combination of pegylated IFN-alpha 2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia. Blood. ISSN 0006-4971. 118(12), p. 3228–3235. doi: 10.1182/blood-2011-02-336685.
  • Frøyland, Marianne; Ruffini, Pier Adelchi; Thompson, Keith M; Gedde-Dahl, Thobias; Fredriksen, Agnete & Bogen, Bjarne (2011). Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing . European Journal of Haematology. ISSN 0902-4441. 86(5), p. 385–395. doi: 10.1111/j.1600-0609.2011.01590.x.
  • Johnsen, Hans; Klausen, Tobias W.; Boegsted, Martin; Lenhoff, Stig; Gimsing, Peter & Christiansen, Ilse [Show all 9 contributors for this article] (2010). Improved Survival for Multiple Myeloma in Denmark Based on Autologous Stem Cell Transplantation and Novel Drug Therapy in Collaborative Trials: Analysis of Accrual, Prognostic Variables, Selection Bias, and Clinical Behavior on Survival in More Than 1200 Patients in Trials of the Nordic Myeloma Study Group. Clinical Lymphoma, Myeloma & Leukemia. ISSN 2152-2650. 10(4), p. 290–296. doi: 10.3816/CLML.2010.n.060.
  • Corthay, Alexandre; Lundin, Katrin; Munthe, Ludvig Andre; Frøyland, Marianne; Gedde-Dahl, Thobias & Dembic, Zlatko [Show all 7 contributors for this article] (2004). Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models. Cancer Immunology and Immunotherapy. ISSN 0340-7004. 53, p. 759–769.

View all works in Cristin

  • Horn, Morten Andreas; Myhre, Anders Eivind; Prescott, Trine; Aasly, Jan; Sundal, Christina Heidemann & Gedde-Dahl, Tobias (2022). Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related Leukoencephalopathy. Movement Disorders. ISSN 0885-3185. 37(5), p. 1108–1109. doi: 10.1002/mds.29011.
  • Grønvold, Bjørn Christer Linder; Ali, M.M.; Remberger, M.; Mattsson, J.; Egeland, Torstein & Lundin, Katrin [Show all 13 contributors for this article] (2020). HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation. Bone Marrow Transplantation. ISSN 0268-3369. 55(8), p. 1658–1661. doi: 10.1038/s41409-020-0827-3.
  • Abrahamsen, Ingerid Weum; Grønvold, Bjørn Christer; Inderberg, Else Marit ; Mensali, Nadia; Mattsson, Jonas & Gedde-Dahl, Tobias (2020). Posttransplantation Lymphoproliferative Disease Treated by Retransplantation. Case reports in immunology. ISSN 2090-6609. 2020. doi: 10.1155/2020/9403123. Full text in Research Archive
  • Fevang, Børre; Fagerli, Unn Merete; Sorte, Hanne Sørmo; Aarset, Harald; Hov, Håkon & Langmyr, Marit [Show all 11 contributors for this article] (2018). Runaway Train; A Leaky Radiosensitive SCID with Skin Lesions and Multiple Lymphomas. Hindawi (Case Reports in Immunology). doi: 10.1155/2018/2053716.
  • Bruserud, Øystein; Melve, Guro Kristin; Gedde-Dahl, Thobias & Tvedt, Tor Henrik Anderson (2018). Immunological heterogeneity of healthy peripheral blood stem cell donors?preharvesting donor characteristics, additional heterogeneity induced by granulocyte colony-stimulating factor and possible importance for outcome after allotransplantation. Expert Review of Hematology. ISSN 1747-4086. p. 1–3. doi: 10.1080/17474086.2018.1511420.
  • Diep, Phoi Phoi; Melberg, Hans Olav; Brinch, Lorentz; Buechner, Jochen; Fløisand, Yngvar & Gedde-Dahl, Thobias [Show all 9 contributors for this article] (2018). Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway. Bone Marrow Transplantation. ISSN 0268-3369. 53(5), p. 657–660. doi: 10.1038/s41409-018-0091-y.
  • Ayuda-Duran, Maria del Pilar; Zhang, B; Piechaczyck, L.; Popa, Mihaela Lucia; Tadele, Dagim Shiferaw & Rowe, Alexander D. [Show all 12 contributors for this article] (2017). a precision medicin platform for acute myeloid leukemia to help unraveling the molecular addictions of FLT3-ITD-driven AML.
  • Diep, Phoi Phoi; Melberg, Hans Olav; Brinch, Lorentz; Buechner, Jochen; Fløisand, Yngvar & Gedde-Dahl, Thobias [Show all 8 contributors for this article] (2017). Allogeneic hematopoietic stem cell transplantation in Norway 1974-2009: Cost-utility and survival in children and young adults .
  • Koenecke, Christian; Heim, Dominik; Van Biezen, Anja A.; Heuser, Michael; Aljurf, Mahmoud Deeb Saeed & Kyrcz-Krzemień, Sławomira [Show all 20 contributors for this article] (2016). Outcome of patients with chronic myeloid leukemia and a low-risk score: Allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party. Bone Marrow Transplantation. ISSN 0268-3369. 51(9), p. 1259–1261. doi: 10.1038/bmt.2016.97.
  • Bazarbachi, Ali; Labopin, Myriam; Kharfan-Dabaja, Mohamed A.; Schwerdtfeger, Rainer; Volin, Liisa & Bourhis, Jean Henri [Show all 19 contributors for this article] (2015). Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: Outcome strongly correlates with disease status. Haematologica. ISSN 0390-6078. 101(1), p. e34–e37. doi: 10.3324/haematol.2015.135681.
  • Bremer, Sara; Fløisand, Yngvar; Brinch, Lorentz; Gedde-Dahl, Thobias & Bergan, Stein (2013). Pharmacogenetics of busulfan: significant association between GSTA1 genotype, busulfan pharmacokinetics and short term toxicity. Bone Marrow Transplantation. ISSN 0268-3369. 48, p. S227–S228.
  • Simonsson, Bengt; Gedde-Dahl, Thobias; Markevärn, Berit; Remes, Kari; Stentoft, Jesper & Almqvist, Anders [Show all 29 contributors for this article] (2010). MAJOR MOLECULAR RESPONSE RATE AT ONE YEAR IS HIGHER IF PEGYLATED INTERFERON ALPHA-2B IS ADDED TO IMATINIB IN NON-HR CHRONIC MYELOID LEUKEMIA PATIENTS IN IMATINIB INDUCED COMPLETE HEMATOLOGICAL REMISSION. Haematologica. ISSN 0390-6078. 95, p. 457–457.
  • Heldal, Dag; Brinch, Lorentz; Fløisand, Yngvar; Dybedal, Ingunn; Gedde-Dahl, Thobias & Holme, Pål Andre [Show all 8 contributors for this article] (2010). Long-term (>= 5 years) follow-up of a randomized study of allogeneic stem cell transplantation with stem cells from blood or bone marrow. Bone Marrow Transplantation. ISSN 0268-3369. 45, p. S155–S156.
  • Brinch, Lorentz; Fløisand, Yngvar; Tjønnfjord, Geir Erland; Gedde-Dahl, Thobias; Heldal, Dag & Holme, Pål Andre [Show all 7 contributors for this article] (2009). Allogeneic blood stem cell transplants for AML using the Bu4Cy2 regimen in AML: long term experience. Bone Marrow Transplantation. ISSN 0268-3369. 43, p. S98–S98.
  • Simonsson, Bengt; Gedde-Dahl, Thobias; Markevarn, B; Remes, Kari; Stentoft, J & Almqvist, Anders [Show all 28 contributors for this article] (2009). A Randomized Phase II Study Comparing Imatinib and the Combination of Imatinib and Pegylated Interferon Alpha-2b in Newly Diagnosed Non-High Risk Chronic Myeloid Leukemia (CML) Patients in Complete Hematological Remission After Imatinib Induction Therapy. Blood. ISSN 0006-4971. 114(22), p. 1269–1270.
  • Van Maldergem, L; Magre, J; Gedde-Dahl, Thobias; Khallouf, E; Lathrop, M & Capeau, J [Show all 7 contributors for this article] (2003). Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. European Journal of Human Genetics. ISSN 1018-4813. 10, p. 70–70.
  • Giske, Liv; Stoinska-Schneider, Anna; Lund Håheim, Lise; Juvet, Lene Kristine; Gunnarsson, Ragnar & Gedde-Dahl, Thobias [Show all 8 contributors for this article] (2018). Autolog hematopoietisk stamcelletransplantasjon (AHSCT) ved diffus systemisk sklerose. Folkehelseinstituttet. ISSN 978‐82‐8082‐944‐3. Full text in Research Archive

View all works in Cristin

Published Feb. 16, 2017 11:04 AM - Last modified Feb. 20, 2017 11:16 AM